GE HealthCare Technologies Long Term Debt 2020-2024 | GEHC
GE HealthCare Technologies long term debt from 2020 to 2024. Long term debt can be defined as the sum of all long term debt fields.
- GE HealthCare Technologies long term debt for the quarter ending September 30, 2024 was $9.306B, a 9.24% decline year-over-year.
- GE HealthCare Technologies long term debt for 2023 was $8.436B, a 2.45% increase from 2022.
- GE HealthCare Technologies long term debt for 2022 was $8.234B, a 26461.29% increase from 2021.
- GE HealthCare Technologies long term debt for 2021 was $0.031B, a 0% decline from 2020.
| GE HealthCare Technologies Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2023 | $8,436 |
| 2022 | $8,234 |
| 2021 | $31 |
| 2020 | $31 |
| 2019 | $ |
| GE HealthCare Technologies Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2024-09-30 | $9,306 |
| 2024-06-30 | $8,233 |
| 2024-03-31 | $8,247 |
| 2023-12-31 | $8,436 |
| 2023-09-30 | $10,253 |
| 2023-06-30 | $10,233 |
| 2023-03-31 | $10,234 |
| 2022-12-31 | $8,234 |
| 2022-09-30 | $31 |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2020-12-31 | $31 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $39.725B | $19.552B |
| Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $205.706B | 26.24 |
| Stryker (SYK) | United States | $139.963B | 31.54 |
| Boston Scientific (BSX) | United States | $123.141B | 35.43 |
| Medtronic (MDT) | Ireland | $115.512B | 17.19 |
| EssilorLuxottica (ESLOY) | France | $107.269B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.495B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.045B | 28.62 |
| ResMed (RMD) | United States | $35.859B | 29.47 |
| Terumo (TRUMY) | Japan | $28.338B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.899B | 19.06 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.355B | 13.60 |
| Baxter (BAX) | United States | $18.300B | 12.41 |
| Insulet (PODD) | United States | $16.520B | 69.50 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.035B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.268B | 35.05 |
| BellRing Brands (BRBR) | United States | $8.619B | 36.44 |
| Demant (WILYY) | Denmark | $8.351B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.497B | 18.00 |
| ICU Medical (ICUI) | United States | $4.172B | 39.82 |
| TG Therapeutics (TGTX) | United States | $4.165B | 44.10 |
| Prestige Consumer Healthcare (PBH) | United States | $3.670B | 18.28 |
| Haemonetics (HAE) | United States | $3.658B | 18.10 |
| Envista Holdings (NVST) | United States | $3.604B | 26.85 |
| Perrigo (PRGO) | Ireland | $3.559B | 11.25 |
| Neogen (NEOG) | United States | $3.129B | 36.10 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.966B | 17.86 |
| QuidelOrtho (QDEL) | United States | $2.629B | 16.57 |
| Agios Pharmaceuticals (AGIO) | United States | $2.559B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.178B | 36.75 |
| LeMaitre Vascular (LMAT) | United States | $2.132B | 51.85 |
| Curaleaf Holdings (CURLF) | Canada | $1.923B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.882B | 0.00 |
| Warby Parker (WRBY) | United States | $1.756B | 0.00 |
| AtriCure (ATRC) | United States | $1.634B | 0.00 |
| InMode (INMD) | Israel | $1.450B | 8.72 |
| AdaptHealth (AHCO) | United States | $1.412B | 10.19 |
| Verano Holdings (VRNOF) | United States | $1.196B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.111B | 0.00 |
| Evolus (EOLS) | United States | $1.057B | 0.00 |
| Owens & Minor (OMI) | United States | $1.030B | 7.95 |
| Phibro Animal Health (PAHC) | United States | $0.939B | 19.48 |
| CeriBell (CBLL) | United States | $0.899B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.883B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.866B | 27.52 |
| Cresco Labs (CRLBF) | United States | $0.740B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.540B | 16.30 |
| Surmodics (SRDX) | United States | $0.537B | 114.03 |
| Quanterix (QTRX) | United States | $0.515B | 0.00 |
| Valneva SE (VALN) | France | $0.467B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.456B | 0.00 |
| ZimVie (ZIMV) | United States | $0.387B | 32.65 |
| Viemed Healthcare (VMD) | United States | $0.334B | 35.88 |
| Jin Medical (ZJYL) | China | $0.318B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.311B | 8.02 |
| TerrAscend (TSNDF) | Canada | $0.309B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.304B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.293B | 0.00 |
| Biote (BTMD) | United States | $0.284B | 13.07 |
| Cerus (CERS) | United States | $0.282B | 0.00 |
| Zynex (ZYXI) | United States | $0.279B | 58.40 |
| Ayr Wellness (AYRWF) | United States | $0.267B | 0.00 |
| MacroGenics (MGNX) | United States | $0.243B | 0.00 |
| Omeros (OMER) | United States | $0.236B | 0.00 |
| High Tide (HITI) | Canada | $0.230B | 95.33 |
| Utah Medical Products (UTMD) | United States | $0.223B | 15.01 |
| Organigram Holdings (OGI) | Canada | $0.188B | 0.00 |
| Brainsway (BWAY) | Israel | $0.171B | 204.60 |
| FitLife Brands (FTLF) | United States | $0.146B | 19.75 |
| Rockwell Medical (RMTI) | United States | $0.118B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.118B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.113B | 0.00 |
| Veru (VERU) | United States | $0.112B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 9.97 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 23.20 |
| Jushi Holdings (JUSHF) | United States | $0.086B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.084B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.082B | 0.00 |
| InterCure (INCR) | Israel | $0.080B | 0.00 |
| Modular Medical (MODD) | United States | $0.072B | 0.00 |
| Safety Shot (SHOT) | United States | $0.063B | 0.00 |
| MariMed (MRMD) | United States | $0.061B | 0.00 |
| Sanuwave Health (SNWVD) | United States | $0.056B | 1.43 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.046B | 0.00 |
| Exagen (XGN) | United States | $0.045B | 0.00 |
| Apyx Medical (APYX) | United States | $0.041B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Nephros (NEPH) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.007B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 18.04 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |